Annual Report

Overview

The report describes the company launching China's first long-acting recombinant human FSH-CTP, SJ02, and receiving Breakthrough Therapy Designations for KJ103 indications. It also highlights approximately 9,000 tons of water conserved through energy-saving and carbon-reduction initiatives, rooftop photovoltaic generation, and first-year Scope 1 and Scope 2 emissions reporting.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 26 March 2026
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services